Search

everythinglearnresearchcommunity

for

Search:↓

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

Aromatase gene variation may increase female hair loss risk.

Restoring mitochondrial function in mice reversed their skin wrinkling and hair loss.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Children with atopic dermatitis often have sleep problems due to itching and may benefit from melatonin, which helps with sleep and skin symptoms.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Minoxidil absorbs poorly through skin, with low risk of side effects at 1-2% concentration.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

The study found that family history, personal history of adolescent acne, no pregnancies, hirsutism, office work, stress, and low intake of fruits/vegetables and fish are risk factors for adult female acne.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Quercetin may help with PCOS symptoms, but more research is needed.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

Low-Level Light Therapy (LLLT) is a safe and effective method for skin rejuvenation, acne treatment, wound healing, body contouring, and hair growth, but more well-designed trials are needed for confirmation.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Platelet lysate is more effective than activated autologous platelet-rich plasma or saline in improving hair growth after hair restoration surgery.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Melatonin helped some Pomeranian dogs regrow hair, but it wasn't linked to estrogen receptors.